Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | +Options Exercise | $79,298 | +2,118 | +12.25% | $37.44 | 19,404 | Mar 4, 2022 | Direct | |
transaction | EOG | Common Stock | -Disposed to Issuer | -$79,299 | -660 | -3.4% | $120.15 | 18,744 | Mar 4, 2022 | Direct | |
transaction | EOG | Common Stock | -Tax liability | -$42,773 | -356 | -1.9% | $120.15 | 18,388 | Mar 4, 2022 | Direct | |
transaction | EOG | Common Stock | -Sell | -$132,395 | -1,102 | -5.99% | $120.14 | 17,286 | Mar 4, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -2,118 | -33.29% | $0.00 | 4,244 | Mar 4, 2022 | Common Stock | 2,118 | $37.44 | Direct | F1 |
Id | Content |
---|---|
F1 | The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. |